Observational studyBMC pulmonary medicine2025
Small airway lesions appear with the course of IPF and relate to the severity of pulmonary fibrosis progression.
Observational study in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03666234 (Idiopathic Pulmonary Fibrosis Registry China Study), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Idiopathic Pulmonary Fibrosis Registry China Study
Who cites it
2 citing papers in PubMed.
- Small Airway Dysfunction in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Single-Center Retrospective Observational Study.Journal of clinical medicine · 2026Article
- 2025 annual review of basic and translational research advances in pulmonary fibrosis: a narrative review.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimIdiopathic Pulmonary Fibrosis (IPF) has long been considered a disease primarily involving the lung interstitium, with relative sparing of the airways. This study aimed to investigate the presence and characteristics of small airway abnormalities in patients with IPF.
methodsWe analyzed 137 patients with IPF and 84 controls from a prospective, multicenter cohort (trial registration: NCT03666234). IPF patients were stratified by fibrosis severity on CT and clinical disease severity scores. Small airway function was assessed using predicted maximal expiratory flow at 25% (MEF25%), 50% (MEF50%), and 25-75% of forced vital capacity (MEF25-75%). Airway segmentation and quantitative analysis of airway number, length, and volume were performed using FACT-Digital Lung™ software. Group differences were analyzed using SPSS (version 26).
resultsThe IPF group comprised 114 men and 23 women, with a mean age of 64.5 ± 10.7 years. MEF50%, MEF25%, and MEF25-75% were significantly lower in IPF patients than in controls across all severity stages. Conversely, the total number, length, and volume of segmented bronchi were higher in IPF patients, with the most pronounced differences observed in bronchi at generations 9-14. Small airway abnormalities were evident even in patients with mild fibrosis.
conclusionSmall airway abnormalities, including increased airway counts and functional impairment, are detectable in early-stage IPF and persist throughout disease progression, suggesting that small airway involvement is a fundamental feature of IPF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.